Integrated analysis of somatic mutations and immune microenvironment of multiple regions in breast cancers

被引:25
作者
Kato, Taigo [1 ]
Park, Jae-Hyun [1 ]
Kiyotani, Kazuma [1 ]
Ikeda, Yuji [1 ]
Miyoshi, Yasuo [2 ]
Nakamura, Yusuke [1 ,3 ]
机构
[1] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[2] Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Nishinomiya, Hyogo 6638501, Japan
[3] Univ Chicago, Dept Surg, Chicago, IL 60637 USA
关键词
breast cancer; heterogeneity; T cell receptor; non-synonymous mutation; neoantigen; COMPREHENSIVE MOLECULAR PORTRAITS; SEQUENCING DATA; READ ALIGNMENT; HETEROGENEITY; CHEMOTHERAPY; GENERATION; TUMORS; VARIANTS; THERAPY; CELLS;
D O I
10.18632/oncotarget.18790
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Next-generation sequencing technology enables us to analyze the complexity of intra-and inter-tumoral heterogeneity, which may influence to prognosis of cancer patients. In this study, we collected surgically-resected tumor tissues from five breast cancer patients and characterized three different portions of individual tumors through somatic mutation analysis by whole exome sequencing, T cell receptor beta (TCRB) repertoire analysis of tumor-infiltrating lymphocytes (TILs), and the expression analysis of immune-related genes at 15 different sites. This integrated analysis revealed distinguished patterns of somatic mutations and TIL clonotypes in the three portions of each tumor, implying that the tumor heterogeneity is comprised by spatially different somatic mutations as well as the presence of diverse T cell clones. Furthermore, higher numbers of the non-synonymous somatic mutations were significantly correlated with the higher ratio of GZMA/TCRB expression (P = 0.0004), implying that high somatic mutation load in tumor might be correlated to the number of immunogenic antigens and then functionally activate TILs with higher cytolytic activity. Our findings suggest that breast cancers comprise with very complex tumor heterogeneity by the spatially different mutational landscape and immune microenvironment, and that mutation/neoantigen load may be strongly correlated with induction of cancer-specific TILs and affect the immune microenvironment in breast tumors.
引用
收藏
页码:62029 / 62038
页数:10
相关论文
共 34 条
[1]  
Brown M, 2000, CLIN CHEM, V46, P1221
[2]   Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage [J].
Chen, Lu ;
Linden, Hannah M. ;
Anderson, Benjamin O. ;
Li, Christopher I. .
BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (03) :609-616
[3]  
Choudhury NJ, 2015, EUR UROL FOCUS, V2, P445
[4]   Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer [J].
Ciriello, Giovanni ;
Gatza, Michael L. ;
Beck, Andrew H. ;
Wilkerson, Matthew D. ;
Rhie, Suhn K. ;
Pastore, Alessandro ;
Zhang, Hailei ;
McLellan, Michael ;
Yau, Christina ;
Kandoth, Cyriac ;
Bowlby, Reanne ;
Shen, Hui ;
Hayat, Sikander ;
Fieldhouse, Robert ;
Lester, Susan C. ;
Tse, Gary M. K. ;
Factor, Rachel E. ;
Collins, Laura C. ;
Allison, Kimberly H. ;
Chen, Yunn-Yi ;
Jensen, Kristin ;
Johnson, Nicole B. ;
Oesterreich, Steffi ;
Mills, Gordon B. ;
Cherniack, Andrew D. ;
Robertson, Gordon ;
Benz, Christopher ;
Sander, Chris ;
Laird, Peter W. ;
Hoadley, Katherine A. ;
King, Tari A. ;
Perou, Charles M. .
CELL, 2015, 163 (02) :506-519
[5]   Quantitative T cell repertoire analysis by deep cDNA sequencing of T cell receptor α and β chains using next-generation sequencing (NGS) [J].
Fang, Hua ;
Yamaguchi, Rui ;
Liu, Xiao ;
Daigo, Yataro ;
Yew, Poh Yin ;
Tanikawa, Chizu ;
Matsuda, Koichi ;
Imoto, Seiya ;
Miyano, Satoru ;
Nakamura, Yusuke .
ONCOIMMUNOLOGY, 2014, 3 (12) :1-12
[6]   Cancer heterogeneity: implications for targeted therapeutics [J].
Fisher, R. ;
Pusztai, L. ;
Swanton, C. .
BRITISH JOURNAL OF CANCER, 2013, 108 (03) :479-485
[7]   IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes [J].
Giudicelli, W ;
Chaume, D ;
Lefranc, MP .
NUCLEIC ACIDS RESEARCH, 2005, 33 :D256-D261
[8]  
Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]
[9]   NetMHCpan, a method for MHC class I binding prediction beyond humans [J].
Hoof, Ilka ;
Peters, Bjoern ;
Sidney, John ;
Pedersen, Lasse Eggers ;
Sette, Alessandro ;
Lund, Ole ;
Buus, Soren ;
Nielsen, Morten .
IMMUNOGENETICS, 2009, 61 (01) :1-13
[10]   Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma [J].
Inoue, Hiroyuki ;
Park, Jae-Hyun ;
Kiyotani, Kazuma ;
Zewde, Makda ;
Miyashita, Azusa ;
Jinnin, Masatoshi ;
Kiniwa, Yukiko ;
Okuyama, Ryuhei ;
Tanaka, Ryota ;
Fujisawa, Yasuhiro ;
Kato, Hiroshi ;
Morita, Akimichi ;
Asai, Jun ;
Katoh, Norito ;
Yokota, Kenji ;
Akiyama, Masashi ;
Ihn, Hironobu ;
Fukushima, Satoshi ;
Nakamura, Yusuke .
ONCOIMMUNOLOGY, 2016, 5 (09)